Skip to main content

Table 6 Body composition data from baseline to 4 month

From: Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, double-blind trial

 

Group

Baseline

4 months

p value

Mean ± SD

Mean ± SD

Time

Group×Time

Body weight (kg)

W group

76.1 ± 10.2

75.6 ± 11.1

0.743

0.150

EW group

74.9 ± 11.5

75.6 ± 12.1

BMI (kg/m2)

W group

25.2 ± 2.6

25.0 ± 2.8

0.787

0.126

EW group

24.5 ± 2.8

24.7 ± 3.0

Lean body mass (kg)

W group

62.8 ± 7.5

62.4 ± 7.8

0.427

0.645

EW group

61.7 ± 7.1

61.6 ± 7.3

FAT mass (kg)

W group

11.2 ± 4.0

11.2 ± 4.3

0.108

0.101

EW group

11.5 ± 4.9

12.1 ± 5.1

Lower limb fat-free mass (g)

W group

22,710.0 ± 2854.4

23,034.0 ± 2993.4

0.000

0.030

EW group

21,751.4 ± 2915.6

22,701.6 ± 3107.7

Lower limb muscle mass (g)

W group

21,608.5 ± 2708.3

21,864.2 ± 2862.7

0.000

0.020

EW group

20,635.9 ± 2811.6

21,566.7 ± 3005.3

Lower limb fat mass (g)

W group

4368.8 ± 1751.9

4430.7 ± 1798.0

0.013

0.078

EW group

4349.7 ± 1902.8

4692.0 ± 1998.7

  1. Data are mean ± SD; p < 0.05 is considered significant (indicated in bold)